Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Deadline: 2027-04-13 , 2027-09-22 Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and
Read the official notice →Source: EFSA (European Food Safety Authority) · EFSA reuse policy (attribution). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from European Union
- Living Labs for the eradication and/or management of invasive alien species regulatory
- Microbiome for terrestrial livestock sustainability and health within a One Health approach regulatory
- Integrating Remote Sensing and in-situ observations of Biodiversity, towards a fully interoperable observation and data framework regulatory
- Health of ecosystems and wild species, predictions and impacts on human health, in the face of existing and emerging stressors, from a One Health approach regulatory
- Enhancing the competitiveness of organic crop breeding: focus on intercropping adapted varieties regulatory
- Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with EU 1169.